Shandong Huanri Medical Device Co., Ltd.

Shandong Huanri Medical Device Co., Ltd. as a multinational medical group company hereby called "Perfemed Group", which integrates manufacturing, researching and marketing together. Until now, Perfemed has established five production lines including Homecare Products, Patient Monitor Products, In-Vitro Diagnostic Products, Operation Products and Ultrasound Products. Being a developing high-tech enterprise, we continuously devote ourselves to the medical technology innovation and its world-wide popularization. The solid ability in researching and developing is the software support of our technology innovation. The group has a professional R&D team with R&D centers in United States and branches over Beijing, Shandong and Shenzhen. We integrate advanced technologies in and abroad to satisfy our partners&＃39; integration needs from products design, develop, manufacture, installation to after sales. The diversified portfolio of products is the resource advantage of our market competition. The group is devoted to health development in an all-round way, involving Patient Monitor, Anesthesia Machine, ICU Ventilator, Digital Ultrasound, Hematology Analyzer, IVD Diagnostic Products, Homecare Ventilator, Pulse Oximeter, Microplate Reader, Microplate Washer, Erythrocyte Sedimentation Rate Analyzer, CLIA Reagent and ELA Reagent. The group with good reputation and financial strength has already established close partnership with many domestic and foreign medical institues, universities and medical device companies. The huge sales network is the strength reflection of the industry leader. After nearly six years of marketing, our products have been exported to Europe, America, Asia and Africa market in home and abroad. The professional sales team is keeping to provide clients with high quality products and services. Perfemed Group has entered into a stage of rapid growth through hard work with fast increase in scientific research innovation and operational effectiveness. In the next five years, the group will execute spanning development strategy, accelerating the internationalization of medical research and construction of marketing network, to be an advanced medical system solution provider of brand influence and international competitiveness.